Opexa Therapeutics CEO to Present at BIO 2015 International Convention
June 11 2015 - 8:00AM
Business Wire
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a
biopharmaceutical company developing personalized immunotherapies
including multiple sclerosis (MS) and neuromyelitis optica (NMO),
today announced that Neil K. Warma, President and Chief Executive
Officer, will present at the Biotechnology Industry Organization
(BIO) 2015 International Convention on Tuesday, June 16, 2015, at
1:45 p.m. EDT in Theater 1. The conference will be held at The
Pennsylvania Convention Center (June 15-18, 2015, Philadelphia,
PA).
A live webcast of the Company presentation can be accessed here,
or via the Investor Relations section of the Company’s website at
www.opexatherapeutics.com. An archive of the webcast will be
available on the Company's website until September 15, 2015.
About Opexa
Opexa is a biopharmaceutical company developing a personalized
immunotherapy with the potential to treat major illnesses,
including multiple sclerosis (MS) as well as other autoimmune
diseases such as neuromyelitis optica (NMO). These therapies are
based on Opexa’s proprietary T-cell technology. The Company’s
leading therapy candidate, Tcelna®, is a personalized T-cell
immunotherapy that is in a Phase IIb clinical development program
(the Abili-T trial) for the treatment of secondary progressive MS.
Tcelna consists of myelin-reactive T-cells, which are expanded ex
vivo from the patient’s peripheral blood and reintroduced into the
patient in an attenuated form via subcutaneous injections. This
process triggers a potent immune response against specific subsets
of autoreactive T-cells known to attack myelin for each individual
patient.
For more information visit the Opexa Therapeutics website at
www.opexatherapeutics.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150611005058/en/
Opexa Therapeutics, Inc.Karthik Radhakrishnan, 281-775-0600Chief
Financial Officer
Acer Therapeutics Com USD0.01 (NASDAQ:OPXA)
Historical Stock Chart
From Apr 2024 to May 2024
Acer Therapeutics Com USD0.01 (NASDAQ:OPXA)
Historical Stock Chart
From May 2023 to May 2024